UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 20

of 'Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia'

20
TI
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
AU
Lucas CM,Harris RJ,Holcroft AK,Scott LJ,Carmell N,McDonald E, Polydoros F,Clark RE
SO
Leukemia. 2015;
 
AD